[1] |
ZHANG Qinning, YAN Hualing, REN Licuan, JIA Yange , WANG Ruizhi. Inhibition effect of Lycium ruthenicum murr aqueous extract on the apotosis and expression of p16 and p53 in HaCaT cell induced by UVB irradiation[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 645
-648
. |
[2] |
TIAN Jun, ZHU Longfei, LI Qiang, LIShuli, LIU Bangmin, LI Chunying, GAO Tianwen.. Assessment of the efficacy and side effects of systemic corticosteroid in the treatment of patients with progressive vitiligo[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(7): 403
-406
. |
[3] |
BAO Fangfang, , WANG Shufen, , YU Yongxiang, , YU Changping, , YOU Jiabao, , WEI Baojian, , LIU Hong, , ZHANG Furen, ..
Analysis of mycoses and pathogenic fungi in 65751 patients with fungal infection
[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(1): 8
-11
. |
[4] |
WANG Yimeng, GU Xiaoguang, ZHANG Chunlei.. Treatment options for cutaneous T-cell lymphoma (CTCL)[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(9): 572
-576
. |
[5] |
XUE Yan, BI Xinling. Recurrent cutaneous necrotizing eosinophilic vasculitis: a case report and literatures review[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(4): 225
-228
. |
[6] |
LIU Wei, LIU Jiawei, Qian Yuetong, MA Donglai. Update of keratosis lichenoides chronica[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(4): 250
-252
. |
[7] |
LIU Chunyan, LI Yuzhen. Update of necrobiosis lipoidica[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(5): 317
-320
. |
[8] |
WANG Dan, ZHOU Mengdi , LI Hongliang, HE Gonghao, XU Guili. Meta analysis of efficacy and safety of Yupingfeng powder combined with antihistamines for treating chronic urticaria[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(6): 334
-339
. |
[9] |
SI Haipeng, GAO Lili, WANG Jianrong. Expression of matrix metalloproteinase-12 and its tissue inhibitor-1 in the lesions of BCC and SCC[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(8): 457
-459,463
. |
[10] |
DENG Wei, ZHANG Xiaoyan. IL-17 and IL-23 targeting therapies in psoriasis[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(7): 437
-440
. |
|